Regeneron Pharmaceuticals Inc (STU:RGO)
€ 757 -6.6 (-0.86%) Market Cap: 83.82 Bil Enterprise Value: 77.30 Bil PE Ratio: 20.51 PB Ratio: 3.11 GF Score: 98/100

Regeneron Pharmaceuticals Inc at Jefferies London Healthcare Conference Transcript

Nov 20, 2019 / 02:00PM GMT
Release Date Price: €312.2 (+0.90%)
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Yes. So my name is Biren Amin. I'm one of the biotech analysts here at Jefferies. I'd like to welcome everyone to the 2019 London Healthcare Conference. Our next company is Regeneron Pharmaceuticals. We have their CFO, Bob Landry, to give us an overview initially and then followed by a Q&A that I'll moderate.

Robert E. Landry
Regeneron Pharmaceuticals, Inc. - Executive VP of Finance & CFO

Good. So thanks. Hello, everybody. Good afternoon. Good morning and good evening, if you're on our webcast. Happy to be invited here by Jefferies. So we're going to kind of do a dual split here. I'll throw some slides up at a high level, talk through it and then we'll move over and we'll do probably 15, 20 minutes of Q&A, depending upon how quick we can get through everything. We do have a corporate presentation that is on our website, okay? So you can access that at the conclusion of this meeting. And again, comments expressed here today will include forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot